한림대학교성심병원

한보람 교수

031-380-3704
  • 진료과 혈액종양내과

전문진료분야

백혈병, 악성혈액질환(백혈병, 림프종, 다발골수종), 양성혈액질환(백혈구, 혈소판 감소증), 빈혈

전화 예약 1577-1801
교수님사진

(주간) 진료시간표 (2022-08-15 ~ 2022-08-20)

진료시간표
진료시간
오전 외래진료외래진료외래진료
오후 외래진료
교수님 사진

기본정보

학력

학력

한림대학교 의과대학 졸업

한림대학교 의과대학 석사

경력

경력

한림대학교성심병원 인턴, 내과 전공의

삼성서울병원 혈액종양내과 임상강사

서울아산병원 혈액종양내과 임상강사

현) 한림대학교성심병원 혈액종양내과 임상부교수

학회활동

학회활동

대한혈액학회 정회원

대한내과학회 정회원

한국임상암학회 정회원

대한항암요법연구회 정회원

대한암학회 정회원

논문

A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer (JOURNAL OF CANCER)

Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults (PLOS ONE)

Novel genes exhibiting DNA methylation alterations in Korean patients with chronic lymphocytic leukaemia: a methyl-CpG-binding domain sequencing study (SCIENTIFIC REPORTS)

First Report of a Patient With Natural Killer-Lymphoblastic Leukemia/Lymphoma in Korea (Annals of Laboratory Medicine)

Correlation of Thyroid Transcription Factor-1 Expression with EGFR Mutations in Non-Small-Cell Lung Cancer: A Meta-Analysis (MEDICINA-LITHUANIA)

Pathological and Prognostic Impacts of FGFR2 Overexpression in Gastric Cancer: A Meta-Analysis (JOURNAL OF CANCER)

A Myelodysplastic Syndrome with Concurrent Basophilia and Eosinophilia Lacking Oncogenic Mutations in 54 Relevant Genes (CLINICAL LABORATORY)

Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-Line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer (CANCER RESEARCH AND TREATMENT)

Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11 (GASTRIC CANCER)

Clinicopathologic Significance of VHL Gene Alteration in Clear-Cell Renal Cell Carcinoma: An Updated Meta-Analysis and Review (INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES)